Breast cancer-related preferences among women with and without BRCA mutations

被引:33
|
作者
Grann, Victor R. [1 ,2 ]
Patel, Priya [3 ]
Bharthuar, Anubha [4 ]
Jacobson, Judith S. [5 ,6 ]
Warner, Ellen [5 ,7 ]
Anderson, Kristin [8 ]
Warner, Eiran
Tsai, Wei-Yann [2 ]
Hill, Kimberly A. [7 ]
Neugut, Alfred I. [1 ,2 ]
Hershman, Dawn [1 ,2 ]
机构
[1] Columbia Univ Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, Dept Med, New York, NY 10032 USA
[2] Columbia Univ Coll Phys & Surg, Joseph L Mailman Sch Publ Hlth, New York, NY 10032 USA
[3] Univ Penn, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA
[4] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA
[5] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY USA
[6] Columbia Univ, Joseph L Mailman Sch Publ Hlth, New York, NY USA
[7] Univ Toronto, Dept Med, Toronto, ON, Canada
[8] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA
关键词
Preferences; Quality-adjusted life years; Cost-effectiveness; MRI and prophylactic surgery; BRCA1/2; mutations; QUALITY-OF-LIFE; COST-EFFECTIVENESS; DECISION-ANALYSIS; OVARIAN-CANCER; HEALTH-CARE; UTILITY; CARRIERS; CHEMOTHERAPY; PREVENTION; STRATEGIES;
D O I
10.1007/s10549-009-0373-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Preference ratings are used to quantify quality of life in analyses used for health care policymaking. Subjects indicated how many years of their life expectancy they would trade to avoid BRCA mutations, breast/ovarian cancer, and five preventive measures including prophylactic surgery, annual mammograms, and annual magnetic resonance imaging (MRI). Among 243 respondents, both the 83 women with mutations and the 160 controls rated mammography highest (most favorably), MRI next highest, having a child with a mutation lowest, and ovarian cancer next lowest. Controls rated prophylactic surgery higher than cancer (P < 0.01), but women with mutations did not. In logistic regression, controls were twice as willing as women with mutations to trade time except for screening modalities; younger, lower-income, and non-white women were more willing to trade time than older, higher-income, and white women. Our findings support the use of average-risk individuals' time trade-off preference ratings for health care policy development.
引用
收藏
页码:177 / 184
页数:8
相关论文
共 50 条
  • [31] Effect of Yoga Among Women at Risk and With Breast Cancer-Related Lymphedema: A Systematic Review
    Levenhagen, Kimberly
    Davies, Claire
    Perdomo, Marisa
    Ryans, Kathryn
    Gilchrist, Laura
    REHABILITATION ONCOLOGY, 2023, 41 (03) : 129 - 138
  • [32] Exercise for women with or at risk for breast cancer-related lymphedema
    Bicego, Deanna
    Brown, Kathy
    Ruddick, Moraine
    Storey, Dara
    Wong, Corinne
    Harris, Susan R.
    PHYSICAL THERAPY, 2006, 86 (10): : 1398 - 1405
  • [33] Is mammographic breast density a breast cancer risk factor in women with BRCA mutations?
    Passaperuma, K.
    Warner, E.
    Hill, K. A.
    Gunasekara, A.
    Yaffe, M. J.
    EJC SUPPLEMENTS, 2009, 7 (02): : 313 - 313
  • [34] Is Mammographic Breast Density a Breast Cancer Risk Factor in Women With BRCA Mutations?
    Passaperuma, Kavitha
    Warner, Ellen
    Hill, Kimberley A.
    Gunasekara, Anoma
    Yaffe, Martin J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (23) : 3779 - 3783
  • [35] Impact of breast cancer-related lymphedema on working women
    Vignes, Stephane
    Fau-Prudhomot, Pascal
    Simon, Laura
    Sanchez-Brechot, Marie-Laure
    Arrault, Maria
    Locher, Fabrice
    SUPPORTIVE CARE IN CANCER, 2020, 28 (01) : 79 - 85
  • [36] Hospital readmission after a breast cancer-related admission among breast cancer patients with and without heart failure.
    Park, Chanhyun
    Lee, Hyesung
    Jensen, Brian C.
    Schonberg, Mara A.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18717 - E18717
  • [37] BRCA mutations among triple negative breast cancer without family history of breast and ovarian cancer: The Modena family cancer clinic experience
    Molinaro, E.
    Venturelli, M.
    Toss, A.
    Piombino, C.
    Barbieri, E.
    Marcheselli, L.
    Marchi, I.
    Tagliafico, E.
    Cascinu, S.
    Cortesi, L.
    ANNALS OF ONCOLOGY, 2019, 30
  • [38] BRCA1 and BRCA2 mutations and its clinical relevance among egyptian breast cancer women.
    Loutfy, Samah A.
    Fattah, Nasra F. Abdel
    Barakat, Ahmed B.
    Alfarouk, Omar R.
    Hashem, Tarek M.
    Osman, Ahmed M.
    Metwally, Shimaa A.
    Abo-Shadi, Maha A.
    Helal, Amany M.
    Habib, Shaza A.
    El Sherif, Ahmed A.
    El Ghareeb, Abdel Wahab
    Mouneer, Mohamed M.
    Moneer, Manar M.
    Abdel-Wahed, Marwa A.
    Salem, Mona A.
    Salama, Asmaa M. M. M.
    Hafez, Fatma S.
    Agwa, Sara H.
    Elghazaly, Hesham
    El-Mahdy, Manal M.
    Dunning, Mark J.
    El-Khamisy, Sherif F.
    CANCER RESEARCH, 2021, 81 (13)
  • [39] The prevalence of BRCA1 mutations among young women with triple-negative breast cancer
    SR Young
    Robert T Pilarski
    Talia Donenberg
    Charles Shapiro
    Lyn S Hammond
    Judith Miller
    Karen A Brooks
    Stephanie Cohen
    Beverly Tenenholz
    Damini DeSai
    Inuk Zandvakili
    Robert Royer
    Song Li
    Steven A Narod
    BMC Cancer, 9
  • [40] Prevalence of BRCA1 mutations among 284 women with triple-negative breast cancer
    Fostira, F.
    Tsitlaidou, M.
    Gogas, H.
    Pertesi, M.
    Yannoukakos, D.
    Bournakis, E.
    Karavassilis, V.
    Skarlos, P.
    Konstantopoulou, I.
    Fountzilas, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)